Jörg Ellinger

35PUBLICATIONS
107CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Molecular targetsComputational linguisticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 18, 2026
Segment-based comparison of multiparametric MRI, Gallium-68-PSMA-PET/CT and combined imaging with histopathology in prostate cancer.

|Sep 17, 2026
Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial.

|Dec 20, 2024
The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell Lines.

Richard Weiten, Theadora Engler, Hubert Schorle

|May 16, 2024
Urology consultants versus large language models: Potentials and hazards for medical advice in urology.

Johanna Eckrich, Jörg Ellinger, Alexander Cox

|May 16, 2024
Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer.

Thomas Büttner, Niklas Klümper, Richard Weiten

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

Pageof 6

Frequent Collaborators

10 joint publications

Philipp Krausewitz

10 joint publications

Niklas Klümper

5 joint publications

Thomas Büttner

3 joint publications

Glen Kristiansen